Method of evaluating drug effect in a multiple dose clinical tri

Details Method of evaluating drug effect in a multiple dose clinical tri Method of evaluating drug effect in a multiple dose clinical tri

1999-01-04

2000-03-28

Hindenburg, Max

Surgery

Miscellaneous

Methods

A61B 1900

Patent

active

060417889

ABSTRACT:
The invented method is a process to evaluate drug effect in a multiple dose clinical trial. In drug development, finding an optimal dose is normally carried out by a phase II clinical trial. Then a phase III clinical trial will be conducted to demonstrate the selected dose is efficacious and safe. Because the highest observed response rate among the multiple dose groups could overestimate the true response rate of the selected dose, there is difficulty to pool the data from phase II clinical trial with the data from phase III clinical trial for final analysis. As a result, sample size of each dose group in phase II clinical trials is often under-powered to provide sufficient information for choosing an optimal dose. The invented method gives a solution to the overestimation problem. Simulations show that the invented method is better than the existing methods such as Bonferroni's procedure. The method can be used to evaluate a test drug, compare the test drug with a standard treatment, and determine an appropriate sample size when designing a clinical trial. Results of this method could support a New Drug Application and its market promotion. After all, the invented method is applicable to clinical trials in which drug effect is measured by dichotomous variables as well as continuous variables.

REFERENCES:
patent: 5715180 (1998-02-01), Hu
patent: 5783408 (1998-07-01), Hamilton et al.
patent: 5946662 (1999-08-01), Ettl et al.
A.J. Sankoh et al. :"Some Comments on Frequency Used Multiple Endpoint Adjustment Methods in Clinical Trials", Statistics in Medicine, vol. 16, pp. 2529-2542, 1997.
R.B. D'Agostino et al. :"Strategies for Dealing with Multiple Treatment Comparasons in Confirmatory Clinical Trials", Drug Information Journal, vol. 27, pp. 625-641, 1993.
J.M. Lachin :"Introduction to Sample Size Determination and Power Analysis for Clinical Trials", Controlled Clinical Trials, vol. 2, pp. 93-113, 1981.
R. Makuch et al. :"Sample Size for Evaluating a Conservative Therapy", Cancer Treatment Reports, vol. 62, No. 7, pp. 1037-1040, Jul. 1978.

Affiliated with

Also associated with

Rating

Method of evaluating drug effect in a multiple dose clinical tri does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of evaluating drug effect in a multiple dose clinical tri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of evaluating drug effect in a multiple dose clinical tri will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1317072